NexGenRx Reports Q1 Net Income of C$1.23M and EBITDA of C$1.44M
NexGenRx (TSXV:NXG:CA) reported a net income of C$1,228,288 for the first quarter, up by C$701,078 compared to Q1 2025. The company also recorded EBITDA of C$1,444,036 and total revenue of C$4,997,521, reflecting an 11.62% year-over-year increase.
